Oncotect Information

View Top Employees from Oncotect

Oncotect is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine. The company’s patent-pending in-vitro scientific test combines its proprietary technology and C. elegans’ highly effective olfactory receptors to detect cancerous volatile metabolites. Oncotect is the only urine-based non-invasive, convenient, affordable, and accessible multi-cancer screening test available to dogs.

Website	https://oncotect.co/
Employees	2 (2 on RocketReach)
Address	1009 Capability Drive Research Building II # 301A, Raleigh, North Carolina 27606, US
Industry	Veterinary Services
Keywords	Veterinary Oncology, Early Cancer Detection, Cancer Risk Assessment, Pet Health Diagnostics, Non Invasive Cancer Test, Cancer Biomarkers, Cancer Prevention, Animal Health Technology, In Vitro Diagnostics, Canine Health, Veterinary Diagnostics, Animal Diagnostics, Companion Animal Health, Proprietary Technology

Oncotect Questions

Who is the Founder and CEO of Oncotect?

Chan Namgong is the Founder and CEO of Oncotect.

How many people are employed at Oncotect?

2 people are employed at Oncotect.

Where is Oncotect based?

Oncotect is based in Raleigh, North Carolina.

Top Oncotect Employees

Chan Namgong

Founder and CEO at Oncotect

Raleigh, NC, US
3
- gmail.com
- commercialspacemanagement.com
- oncotect.co
5
- +1 919-818-XXXX
- +1 919-829-XXXX
- +1 919-818-XXXX
- +1 252-756-XXXX
- +1 919-676-XXXX
Jenna Marks

Laboratory Technician at Oncotect

Raleigh, NC, US

View Similar People

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.